Literature DB >> 19471659

Comparison between L and E gene amplification analytical methods for human papillomavirus typing.

Hong-Bum Cho1, Young-Jae Kim, Kyung-Tai Kim.   

Abstract

OBJECTIVE: L and E6/E7 gene amplification analyses were compared to identify human papillomavirus (HPV) infection and verify the HPV type, with the intent to minimize HPV typing errors.
METHODS: L1 gene verified HPV typing was accomplished via polymerase chain reaction (PCR) and membrane assays. Verification of HPV typing via E6/E7 genes was accomplished through nested multiplexed PCR. The results from 104 samples were compared.
RESULTS: The rates of accordance and difference were 35% and 65%, respectively. For 29% of the analyses, nested multiplexed PCR was more diversified than the membrane assay.
CONCLUSION: HPV can be classified into low-risk HPV and high-risk HPV groups. In parallel amplifications of the L and E genes is more efficient for accurate diagnosis in light of the different symptoms and attendant precautions of the risk groups.

Entities:  

Keywords:  E6/E7 gene; Human papillomavirus; L1 gene

Year:  2008        PMID: 19471659      PMCID: PMC2676489          DOI: 10.3802/jgo.2008.19.4.251

Source DB:  PubMed          Journal:  J Gynecol Oncol        ISSN: 2005-0380            Impact factor:   4.401


  15 in total

1.  A new PCR-based assay amplifies the E6-E7 genes of most mucosal human papillomaviruses (HPV).

Authors:  T Sasagawa; Y Minemoto; W Basha; H Yamazaki; M Nakamura; H Yoshimoto; J Sakaike; M Inoue
Journal:  Virus Res       Date:  2000-04       Impact factor: 3.303

Review 2.  Management of anogenital warts (condylomata acuminata).

Authors:  G von Krogh
Journal:  Eur J Dermatol       Date:  2001 Nov-Dec       Impact factor: 3.328

Review 3.  Adherence to care plan in women with abnormal Papanicolaou smears: a review of barriers and interventions.

Authors:  N Khanna; M D Phillips
Journal:  J Am Board Fam Pract       Date:  2001 Mar-Apr

Review 4.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

Review 5.  Human papillomavirus antigens and T-cell recognition.

Authors:  J Luxton; P Shepherd
Journal:  Curr Opin Infect Dis       Date:  2001-04       Impact factor: 4.915

6.  Against which human papillomavirus types shall we vaccinate and screen? The international perspective.

Authors:  Nubia Muñoz; F Xavier Bosch; Xavier Castellsagué; Mireia Díaz; Silvia de Sanjose; Doudja Hammouda; Keerti V Shah; Chris J L M Meijer
Journal:  Int J Cancer       Date:  2004-08-20       Impact factor: 7.396

Review 7.  Human papillomavirus immortalization and transformation functions.

Authors:  Karl Münger; Peter M Howley
Journal:  Virus Res       Date:  2002-11       Impact factor: 3.303

Review 8.  Classification of papillomaviruses.

Authors:  Ethel-Michele de Villiers; Claude Fauquet; Thomas R Broker; Hans-Ulrich Bernard; Harald zur Hausen
Journal:  Virology       Date:  2004-06-20       Impact factor: 3.616

Review 9.  Pathogenesis of human papillomaviruses in differentiating epithelia.

Authors:  Michelle S Longworth; Laimonis A Laimins
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

Review 10.  Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking.

Authors:  Xavier Castellsagué; Nubia Muñoz
Journal:  J Natl Cancer Inst Monogr       Date:  2003
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.